@article{oai:tsukuba.repo.nii.ac.jp:00041109,
 author = {Yamazaki, Naoya and Takenouchi, Tatsuya and 藤本, 学 and FUJIMOTO, Manabu and Ihn, Hironobu and Uchi, Hiroshi and Inozume, Takashi and Kiyohara, Yoshio and Uhara, Hisashi and Nakagawa, Kazuhiko and Furukawa, Hiroshi and Wada, Hidefumi and Noguchi, Kazuo and Shimamoto, Takashi and Yokota, Kenji},
 issue = {4},
 journal = {Cancer chemotherapy and pharmacology},
 month = {Apr},
 pages = {651--660},
 title = {Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041)},
 volume = {79},
 year = {2017},
 yomi = {フジモト, マナブ}
}